摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-(5-hydroxypentynyl)-dUrd | 77876-01-8

中文名称
——
中文别名
——
英文名称
5-(5-hydroxypentynyl)-dUrd
英文别名
1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-(5-hydroxypent-1-ynyl)pyrimidine-2,4-dione;1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-(5-hydroxypent-1-ynyl)pyrimidine-2,4-dione
5-(5-hydroxypentynyl)-dUrd化学式
CAS
77876-01-8
化学式
C14H18N2O6
mdl
——
分子量
310.307
InChiKey
MTJSWISCRCFSQT-QJPTWQEYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.2
  • 重原子数:
    22
  • 可旋转键数:
    5
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.57
  • 拓扑面积:
    119
  • 氢给体数:
    4
  • 氢受体数:
    6

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为产物:
    描述:
    5-iodo-3',5'-di-O-p-toluyl-2'-deoxyuridine 在 bis-triphenylphosphine-palladium(II) chloride 、 copper(l) iodidesodium methylate 作用下, 以 甲醇三乙胺 为溶剂, 反应 4.0h, 生成 5-(5-hydroxypentynyl)-dUrd
    参考文献:
    名称:
    核酸相关化合物。31.末端炔烃与5-碘尿嘧啶核苷的平滑高效钯钯催化偶联
    摘要:
    在三乙胺中存在二氯双(三苯基膦)钯和碘化铜(I)的情况下,末端炔烃与受保护的5-碘尿嘧啶核苷的偶联以72-92%的收率得到相应的5-(炔-1-基)尿嘧啶核苷。
    DOI:
    10.1016/0040-4039(81)80115-3
点击查看最新优质反应信息

文献信息

  • Nucleic acid related compounds. 31. Smooth and efficient palladium-copper catalyzed coupling of terminal alkynes with 5-iodouracil nucleosides
    作者:Morris J. Robins、Philip J. Barr
    DOI:10.1016/0040-4039(81)80115-3
    日期:1981.1
    Coupling of terminal alkynes with protected 5-iodouracil nucleosides in the presence of dichlorobis(triphenylphosphine)palladium and copper(I) iodide in triethylamine gives the corresponding 5-(alkyn-1-yl)uracil nucleosides in 72–92% yields.
    在三乙胺中存在二氯双(三苯基膦)钯和碘化铜(I)的情况下,末端炔烃与受保护的5-碘尿嘧啶核苷的偶联以72-92%的收率得到相应的5-(炔-1-基)尿嘧啶核苷。
  • [EN] ANTI-VIRAL PYRIMIDINE NUCLEOSIDE ANALOGUES<br/>[FR] ANALOGUES DE NUCLEOSIDES DE PYRIMIDINE ANTIVIRAUX
    申请人:UNIV CARDIFF
    公开号:WO1998049177A1
    公开(公告)日:1998-11-05
    A compound having formula (I), wherein R is selected from the group comprising C5 to C20 alkyl, C5 to C20 cycloalkyl, halogens, aryl and alkylaryl; R' is selected from the group comprising hydrogen, alkyl, cycloalkyl, halogens, amino, alkylamino, dialkylamino, nitro, cyano, alkyoxy, aryloxy, thiol, alkylthiol, arythiol, alkyl; R'' is selected from the group comprising hydrogen, alkyl, cycloalkyl, halogens, alkyloxy, aryloxy and aryl; Q is selected from the group comprising O, S and CY2, where Y may be the same or different and is selected from H, alkyl and halogens; X is selected from the group comprising O, NH, S, N- alkyl, (CH2)n where n is 1 to 10, and CY2 where Y may be the same or different and is selected from hydrogen, alkyl and halogens; Z is selected from the group comprising O, S, NH, and N alkyl; U'' is H and U' is selected from H and CH2T, or U' and U'' are joined so as to form a ring moiety including Q wherein U'-U'' together is respectively selected from the group comprising -CTH-CT'T''- and -CT=CT- and -CT'=CT'-, so as to provide ring moieties selected from the group comprising formula (II) and (III) wherein T is selected from the group comprising OH, H, halogens, O-alkyl, O-acyl, O-aryl, CN, NH2 and N3; T' is selected from the group comprising H and halogens and where more than one T' is present they may be the same or different; T'' is selected from the group comprising H and halogens, and W is selected from the group comprising H, a phosphate group and a pharmacologically acceptable salt, derivative or prodrug thereof shows potent anti-viral activity against, for example, varicella zoster virus and cytomegalovirus.
    化合物的化学式为(I),其中R选择自C5到C20烷基,C5到C20环烷基,卤素,芳基和烷基芳基的群体;R'选择自氢,烷基,环烷基,卤素,氨基,烷基氨基,双烷基氨基,硝基,氰基,烷氧基,芳氧基,硫醇,烷硫醇,芳硫醇,烷基;R''选择自氢,烷基,环烷基,卤素,烷氧基,芳氧基和芳基;Q选择自O,S和CY2的群体,其中Y可以相同或不同,选择自氢,烷基和卤素;X选择自O,NH,S,N-烷基,(CH2)n,其中n为1至10,和CY2,其中Y可以相同或不同,选择自氢,烷基和卤素;Z选择自O,S,NH和N烷基;U''为H,U'选择自H和CH2T,或U'和U''结合形成包括Q的环基,其中U'-U''分别选择自-CTH-CT'T''-和-CT=CT-和-CT'=CT'-,从而提供从化学式(II)和(III)中选择的环基,其中T选择自OH,H,卤素,O-烷基,O-酰基,O-芳基,CN,NH2和N3;T'选择自H和卤素,当存在多个T'时,它们可以相同或不同;T''选择自H和卤素,W选择自H,磷酸盐基团和药理学上可接受的盐,衍生物或前药,表现出强大的抗病毒活性,例如对带状疱疹病毒和巨细胞病毒。
  • ANTI-VIRAL PYRIMIDINE NUCLEOSIDE ANALOGUES
    申请人:University College Cardiff Consultants Limited
    公开号:EP0980377A1
    公开(公告)日:2000-02-23
  • US6573247B1
    申请人:——
    公开号:US6573247B1
    公开(公告)日:2003-06-03
  • Nucleic acid related compounds. 39. Efficient conversion of 5-iodo to 5-alkynyl and derived 5-substituted uracil bases and nucleosides
    作者:Morris J. Robins、Philip J. Barr
    DOI:10.1021/jo00159a012
    日期:1983.6
查看更多